NCT03786679 (NOSWEPH) is a NA clinical trial of Ultrasling ER III orthosis in Proximal Humeral Fracture, sponsored by Lars Adolfsson.

Who is sponsoring NCT03786679?

NCT03786679 is sponsored by Lars Adolfsson.

What drugs are being tested in NCT03786679?

Interventions in NCT03786679: Ultrasling ER III orthosis.

What condition does NCT03786679 study?

NCT03786679 studies Proximal Humeral Fracture.

Is NCT03786679 still recruiting?

NCT03786679 is currently status unknown. Last updated 8 March 2023.

Last reviewed 2023-03-08 · How we verify

NCT03786679: NOSWEPH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Non-operative Treatment in Sweden of Proximal Humeral Fractures

Status unknown NA Last updated 8 March 2023

What this trial tests

NA trial testing Ultrasling ER III orthosis in Proximal Humeral Fracture in 400 participants. Status unknown.

Timeline

25 February 2019

Primary endpoint
25 February 2024

25 February 2024

Quick facts

Lead sponsor	Lars Adolfsson
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	400
Start date	25 February 2019
Primary completion	25 February 2024
Estimated completion	25 February 2024
Sites	1 location across Sweden

Drugs / interventions tested

Ultrasling ER III orthosis

Conditions studied

Proximal Humeral Fracture — all drugs for Proximal Humeral Fracture →

Sponsor

Lars Adolfsson

Who can join

18 and older, any sex, with Proximal Humeral Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Proximal humeral fractures are common especially in the elderly population. The majority of these fractures are minimally displaced and may be treated non-operatively. There is however a controversy about which fractures that need surgery and randomised trials have not been able to show a clinically important advantage in patient reported outcome measures for those operated. The trend is therefore that also displaced and comminute fractures are treated non-operatively. There is however very little scientific support for how the non-operative treatment should be designed and performed. Therefore this prospective multicenter study is aiming at investigating the benefit of a four week immobilisation orthosis as compared to early range of motion exercises for those patients not assigned for surgery one week after the trauma.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Interventions for treating proximal humeral fractures in adults.
Handoll HH, Elliott J, Thillemann TM, Aluko P, et al · · 2022 · cited 79× · PMID 35727196 · DOI 10.1002/14651858.cd000434.pub5
The Benefits and Harms of Early Mobilization and Supervised Exercise Therapy after Non-surgically Treated Proximal Humerus or Distal Radius fracture: A systematic Review and Meta-analysis.
Østergaard HK, Mechlenburg I, Launonen AP, Vestermark MT, et al · · 2021 · cited 17× · PMID 33689149 · DOI 10.1007/s12178-021-09697-5
Immobilization Period for the Non-Operative Treatment of Proximal Humerus Fractures: Systematic Review and Meta-Analysis.
Ataei M, Moradi A, Ebrahimzadeh MH, Rastaghi S, et al · · 2024 · cited 1× · PMID 38716180 · DOI 10.22038/abjs.2023.76126.3519

Verify or expand the search:

Other recruiting trials for Proximal Humeral Fracture

Currently open trials in the same condition.

NCT06416618 — Surgical Versus Non-surgical Treatment of Displaced Proximal Humerus Fracture in Adults Aged 50 to 65 Years · NA · recruiting
NCT05703958 — Exactech Proximal Humerus Fracture Plate System Post Market Clinical Follow-up · recruiting
NCT06444828 — Comparing Outcomes of Non-surgical Versus Surgical Treatment of Shoulder Fractures With Different Shoulder Replacements · NA · active not recruiting
NCT06133920 — Duration of Immobilization After Reverse Total Arthroplasty for Proximal Humerus Fractures · recruiting
NCT04523415 — Researches About Proximal Humerus Fractures · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03786679 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lars Adolfsson
Last refreshed: 8 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03786679.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing